Search

everythinglearnresearchcommunity

for

Search:↓

A patient's hair loss after a browlift surgery improved on its own over 8 months.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Skin symptoms can indicate endocrine disorders and have various treatments.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

PCOS is a hormonal disorder causing infertility and menstrual problems, often linked to obesity and can lead to acne, treated with hormonal and insulin-sensitizing medications.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Androgens and other hormones affect hair growth and skin conditions like acne.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Medical treatments like chemotherapy and radiotherapy can harm sperm production, so freezing sperm before treatment is important for men who want children later.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.